Show sidebar
Show 9 12 18 24
Compare

Retatrutide 20mg

$150.00
Retatrutide (GLP-3) is a triple-receptor agonist (GLP-1/GIP/glucagon) under active clinical investigation for metabolic and weight-related research applications. Supplied as lyophilized powder, 20mg per vial. For research use only.
Add to wishlist
Add to cart
Quick view
Compare

Retatrutide 30mg

$225.00
Retatrutide (GLP-3) is a triple-receptor agonist (GLP-1/GIP/glucagon) under active clinical investigation for metabolic and weight-related research applications. Supplied as lyophilized powder, 30mg per vial. For research use only.
Add to wishlist
Add to cart
Quick view
Compare

Selank 10mg

$90.00
Selank is a synthetic anxiolytic peptide studied for its activity on GABA and serotonin systems in neuroscience and cognitive research. Supplied as lyophilized powder, 10mg per vial. For research use only.
Add to wishlist
Add to cart
Quick view
Compare

Semax 10mg

$80.00
Semax is a synthetic heptapeptide derived from ACTH, studied for its neuroprotective and nootropic properties in cognitive and neurological research models. Supplied as lyophilized powder, 10mg per vial. For research use only.
Add to wishlist
Add to cart
Quick view
Compare

SS-31 50mg

$139.99
SS-31 (Elamipretide) is a mitochondria-targeting peptide studied for its role in mitochondrial membrane stabilization and oxidative stress research. Supplied as lyophilized powder, 50mg per vial. For research use only.
Add to wishlist
Add to cart
Quick view
Compare

Tesamorelin 10mg

$84.99
Tesamorelin is a synthetic GHRH analog studied for its activity in growth hormone secretion and metabolic research. Supplied as lyophilized powder, 10mg per vial. Third-party tested. For research use only.
Add to wishlist
Add to cart
Quick view
Compare

Tirzepatide 60mg

$219.99
Tirzepatide is a dual GIP/GLP-1 receptor agonist widely studied in metabolic research contexts. Supplied as lyophilized powder, 60mg per vial. Third-party tested for identity and purity. For research use only.
Add to wishlist
Add to cart
Quick view